Venture Certified
| 기술평가대출기업(중진공) | 2010-08-19 ~ 2012-08-18 | 20100400668 | - |
| 혁신성장유형 | 2023-07-05 ~ 2026-07-04 | 20230705030022 | 2023-07-05 |
Revenue CAGR +13.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 27.1B | 34.3B | 21.0B |
| Operating Profit | 5.2B | 7.9B | 1.8B |
| Net Profit | 5.2B | 7.9B | 1.9B |
| Total Assets | 49.8B | 46.8B | 37.2B |
| Total Liabilities | 9.2B | 11.0B | 8.9B |
| Total Equity | 40.5B | 35.8B | 28.3B |
▼ 2.1%
▲ 7.4%
▲ 21.8%
▼ 26.7%
▼ 10.4%
| Name | Position | Role |
|---|---|---|
| 한성호 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 영등포구",
"ceo_name": "한성호",
"certificate": [
{
"cert_number": "20100400668",
"changes": "",
"disclosure_date": "2010-08-19",
"first_cert_date": "",
"no": "1",
"type": "기술평가대출기업(중진공)",
"valid_period": "2010-08-19 ~ 2012-08-18"
},
{
"cert_number": "20230705030022",
"changes": "",
"disclosure_date": "2023-07-05",
"first_cert_date": "2023-07-05",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2023-07-05 ~ 2026-07-04"
}
],
"company_name": "주식회사 아디포랩스",
"corp_no": "121111-*******",
"financials": {
"2022": {
"capital_stock": 1000000000,
"cost_of_sales": 752852000,
"current_assets": 3564333000,
"current_liabilities": 577962000,
"gross_profit": 1348967000,
"net_income": 192830000,
"net_income_bs": 190747000,
"non_current_assets": 159263000,
"non_current_liabilities": 313000000,
"non_operating_expenses": 29539000,
"non_operating_income": 43723000,
"operating_profit": 178646000,
"revenue": 2101819000,
"sga_expenses": 1170321000,
"total_assets": 3723596000,
"total_equity": 2832634000,
"total_liabilities": 890962000
},
"2023": {
"capital_stock": 1000000000,
"cost_of_sales": 1175919000,
"current_assets": 4555632000,
"current_liabilities": 925659000,
"gross_profit": 2257323000,
"net_income": 790324000,
"net_income_bs": 748075000,
"non_current_assets": 128975000,
"non_current_liabilities": 178238000,
"non_operating_expenses": 26511000,
"non_operating_income": 28454000,
"operating_profit": 788381000,
"revenue": 3433242000,
"sga_expenses": 1468942000,
"total_assets": 4684607000,
"total_equity": 3580710000,
"total_liabilities": 1103897000
},
"2024": {
"capital_stock": 1000000000,
"cost_of_sales": 756547000,
"current_assets": 4858032000,
"current_liabilities": 780139000,
"gross_profit": 1954175000,
"net_income": 524024000,
"net_income_bs": 471266000,
"non_current_assets": 118663000,
"non_current_liabilities": 144580000,
"non_operating_expenses": 23218000,
"non_operating_income": 27900000,
"operating_profit": 519342000,
"revenue": 2710722000,
"sga_expenses": 1434833000,
"total_assets": 4976695000,
"total_equity": 4051976000,
"total_liabilities": 924719000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [],
"main_products": "의료기기",
"phone": "02-2634-****",
"years": [
2024,
2023,
2022
]
}